Global strategy for asthma management and prevention: GINA executive summary
- E. Bateman, S. Hurd, H. Zar
- MedicineEuropean Respiratory Journal
- 1 January 2008
It is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained, and the Global Initiative for Asthma recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions.
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *
- J. Bousquet, N. Khaltaev, D. Williams
- BiologyAllergy. European Journal of Allergy and Clinical…
- 1 April 2008
The Zar Review Group: I.J. Bousquet, N. Khaltaev, A. R. Rabe, J. Rosado-Pinto, G. Scadding, F. Simons, E. Togias, T. Valovirta, P. Vandenplas, D. Wang, M. Stoloff, O. Williams.
Allergic rhinitis and its impact on asthma.
- J. Bousquet, P. Van cauwenberge, N. Khaltaev
- MedicineJournal of Allergy and Clinical Immunology
- 1 November 2001
This systematic review and meta-analyses confirmed the findings of a previous study published in “Rhinitis and Asthma: Causes and Prevention, 2nd Ed.” (2015) as well as new findings of “Mechanisms of Respiratory Disease and Allergology,” which confirmed the role of EMTs in the development of these diseases.
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
- J. Brożek, J. Bousquet, H. Schünemann
- MedicineJournal of Allergy and Clinical Immunology
- 1 September 2010
Asthma. From bronchoconstriction to airways inflammation and remodeling.
- J. Bousquet, P. Jeffery, W. Busse, M. Johnson, A. Vignola
- Medicine, BiologyAmerican Journal of Respiratory and Critical Care…
- 1 May 2000
This work has shown that chronic inflammation in the different forms of Asthma can affect both the severity and duration of the symptoms of the disease and the treatment options for these conditions vary greatly.
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.
- E. Juniper, J. Bousquet, L. Abetz, E. Bateman
- MedicineRespiratory Medicine
- 1 April 2006
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
- J. Brożek, J. Bousquet, H. Schünemann
- MedicineJournal of Allergy and Clinical Immunology
- 1 October 2017
A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force
- S. Johansson, J. Hourihane, B. Wüthrich
- MedicineAllergy. European Journal of Allergy and Clinical…
- 1 September 2001
The aim of this report is to propose a revised nomenclature for allergic and related reactions that can be used independently of target organ or patient age group.
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
- M. Humbert, R. Beasley, K. Surrey
- MedicineAllergy. European Journal of Allergy and Clinical…
- 1 March 2005
The effect of omalizumab on clinically significant asthma exacerbations (requiring systemic corticosteroids) is determined in the first omalIZumab study to exclusively enrol patients from this difficult‐to‐treat patient population.
Eosinophilic inflammation in asthma.
- J. Bousquet, P. Chanez, P. Godard
- Medicine, BiologyNew England Journal of Medicine
- 11 October 1990
Eosinophilic inflammation of the airways is correlated with the severity of asthma and these cells are likely to play a part in the epithelial damage seen in this disease.
...
...